Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool Healthcare Analyst. Before The Motley Fool, Prosper wrote content for various companies, covering everything from stock market news to private equity investing. He holds an M.S. in Corporate Finance from the University of Maryland Global Campus. Fun fact: French is Prosper’s first language.
Recent Articles by Prosper Junior Bakiny

Jan 4, 2025
by Prosper Junior Bakiny
Better Buy: Novo Nordisk vs. AstraZeneca

Dec 27, 2024
by Prosper Junior Bakiny
2 Brilliant Stocks to Buy and Hold for 10 Years

Dec 23, 2024
by Prosper Junior Bakiny
2 Excellent Dividend Stocks to Buy on the Dip

Dec 22, 2024
by Prosper Junior Bakiny
Is AstraZeneca Stock a Buy?

Dec 20, 2024
by Prosper Junior Bakiny
Is Moderna Stock a Buy?

Dec 20, 2024
by Prosper Junior Bakiny
Where Will Summit Therapeutics Be in 5 Years?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.